מכפיל P/S עתידי: NeuroOne Medical Technologies Corporation (NMTC)

NeuroOne Medical Technologies (NMTC) develops thin electrodes for neurosurgery, serving the B2B sector and optimizing component inventories to eliminate disruptions. This chart, provided by GURU.Markets, illustrates the company's projected P/S valuation dynamics, while the 0.70 level captures the latest values. Revenues are based on equipment supplies to neurological centers for the diagnosis of epilepsy and Parkinson's disease.

The commercialization of thin-film electrodes by NeuroOne Medical Technologies (NMTC) activates operating leverage, which, given high R&D expenses, shifts the valuation focus toward revenue growth rates. The expected P/S ratio correlates current market capitalization with projected annual turnover, allowing investors to assess the premium paid for future business scale and track market expectations through the price action of this chart.